Human Immunodeficiency Virus Infection, AIDS, and Smoking Cessation: The Time is Now
Treatments for persons who are infected with human immunodeficiency virus (HIV) or who have developed AIDS have advanced to the point where death is no longer the inevitable outcome of diagnosis. Combination antiretroviral therapy has made HIV infection less of a terminal condition and more of a med...
Gespeichert in:
| Veröffentlicht in: | Clinical infectious diseases 2000-09, Vol.31 (3), p.808-812 |
|---|---|
| Hauptverfasser: | , , , , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 812 |
|---|---|
| container_issue | 3 |
| container_start_page | 808 |
| container_title | Clinical infectious diseases |
| container_volume | 31 |
| creator | Niaura, Raymond Shadel, William G. Morrow, Kathleen Tashima, Karen Flanigan, Timothy Abrams, David B. |
| description | Treatments for persons who are infected with human immunodeficiency virus (HIV) or who have developed AIDS have advanced to the point where death is no longer the inevitable outcome of diagnosis. Combination antiretroviral therapy has made HIV infection less of a terminal condition and more of a medically manageable chronic disease. Thus, efforts to improve the health status and quality of life of HIV-infected persons have become one of the highest treatment priorities for the next decade. Cigarette smoking is highly prevalent among HIV-infected persons, and quitting smoking would greatly improve the health status of these individuals. However, to date, no studies have evaluated the efficacy of a smoking-cessation intervention specifically tailored to this population. This article reviews the evidence and rationale for advancing smoking-cessation treatments specifically tailored to the needs of HIV-infected persons and provides recommendations for future treatment studies. |
| doi_str_mv | 10.1086/314048 |
| format | Article |
| fullrecord | <record><control><sourceid>jstor_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_72411118</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>4461276</jstor_id><oup_id>10.1086/314048</oup_id><sourcerecordid>4461276</sourcerecordid><originalsourceid>FETCH-LOGICAL-c451t-49945c7217f6383b3cd83802085240e154ab65fe8201eca6bc486a127f53d69e3</originalsourceid><addsrcrecordid>eNqF0Mtu1DAUBmALUdEL8AQIGSGxasAnvqa7Mi2dkSpYTKCIjeVxHHA7sQc7EfTtm1FG0xXCG1v6P51j_Qi9BPIeiBIfKDDC1BN0BJzKQvAKno5vwlXBFFWH6DjnW0IAFOHP0CEAAamoOEL1fOhMwIuuG0JsXOutd8He428-DRkvQuts72M4xeeLi-UpNqHByy7e-fATz1zOZhue4fqXw7XvHPYZf45_nqOD1qyze7G7T9DXT5f1bF5cf7lazM6vC8s49AWrKsatLEG2giq6orYZ_0pKonjJiAPOzErw1qmSgLNGrCxTwkApW04bUTl6gt5Nczcp_h5c7nXns3XrtQkuDlnLksF41H_hWIYCxcgjtCnmnFyrN8l3Jt1rIHpbtJ6KHuHr3cRh1bnmke2aHcHbHTDZmnWbTLA-751UlSJsVG8mFYfNv1e9msxt7mPaK8bEWMV2UTHFPvfu7z426U4LSSXX8-8_9E25rD9KIvUNfQCwoaN6</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17881840</pqid></control><display><type>article</type><title>Human Immunodeficiency Virus Infection, AIDS, and Smoking Cessation: The Time is Now</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>JSTOR Archive Collection A-Z Listing</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Niaura, Raymond ; Shadel, William G. ; Morrow, Kathleen ; Tashima, Karen ; Flanigan, Timothy ; Abrams, David B.</creator><creatorcontrib>Niaura, Raymond ; Shadel, William G. ; Morrow, Kathleen ; Tashima, Karen ; Flanigan, Timothy ; Abrams, David B.</creatorcontrib><description>Treatments for persons who are infected with human immunodeficiency virus (HIV) or who have developed AIDS have advanced to the point where death is no longer the inevitable outcome of diagnosis. Combination antiretroviral therapy has made HIV infection less of a terminal condition and more of a medically manageable chronic disease. Thus, efforts to improve the health status and quality of life of HIV-infected persons have become one of the highest treatment priorities for the next decade. Cigarette smoking is highly prevalent among HIV-infected persons, and quitting smoking would greatly improve the health status of these individuals. However, to date, no studies have evaluated the efficacy of a smoking-cessation intervention specifically tailored to this population. This article reviews the evidence and rationale for advancing smoking-cessation treatments specifically tailored to the needs of HIV-infected persons and provides recommendations for future treatment studies.</description><identifier>ISSN: 1058-4838</identifier><identifier>EISSN: 1537-6591</identifier><identifier>DOI: 10.1086/314048</identifier><identifier>PMID: 11017836</identifier><identifier>CODEN: CIDIEL</identifier><language>eng</language><publisher>Chicago, IL: The University of Chicago Press</publisher><subject>Acquired Immunodeficiency Syndrome - prevention & control ; AIDS ; Biological and medical sciences ; Cigarette smoking ; Disease risk ; Epidemiology ; HIV ; HIV infections ; HIV Infections - prevention & control ; HIV/AIDS ; Human immunodeficiency virus ; Human viral diseases ; Humans ; Infections ; Infectious diseases ; Medical sciences ; Physicians ; Preventive medicine ; Smoking Cessation ; Time Factors ; Viral diseases ; Viral diseases of the lymphoid tissue and the blood. Aids</subject><ispartof>Clinical infectious diseases, 2000-09, Vol.31 (3), p.808-812</ispartof><rights>Copyright 2000 The Infectious Diseases Society of America</rights><rights>2000 by the Infectious Diseases Society of America 2000</rights><rights>2001 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c451t-49945c7217f6383b3cd83802085240e154ab65fe8201eca6bc486a127f53d69e3</citedby><cites>FETCH-LOGICAL-c451t-49945c7217f6383b3cd83802085240e154ab65fe8201eca6bc486a127f53d69e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/4461276$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/4461276$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>314,780,784,803,27924,27925,58017,58250</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=789804$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11017836$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Niaura, Raymond</creatorcontrib><creatorcontrib>Shadel, William G.</creatorcontrib><creatorcontrib>Morrow, Kathleen</creatorcontrib><creatorcontrib>Tashima, Karen</creatorcontrib><creatorcontrib>Flanigan, Timothy</creatorcontrib><creatorcontrib>Abrams, David B.</creatorcontrib><title>Human Immunodeficiency Virus Infection, AIDS, and Smoking Cessation: The Time is Now</title><title>Clinical infectious diseases</title><addtitle>Clinical Infectious Diseases</addtitle><addtitle>Clinical Infectious Diseases</addtitle><description>Treatments for persons who are infected with human immunodeficiency virus (HIV) or who have developed AIDS have advanced to the point where death is no longer the inevitable outcome of diagnosis. Combination antiretroviral therapy has made HIV infection less of a terminal condition and more of a medically manageable chronic disease. Thus, efforts to improve the health status and quality of life of HIV-infected persons have become one of the highest treatment priorities for the next decade. Cigarette smoking is highly prevalent among HIV-infected persons, and quitting smoking would greatly improve the health status of these individuals. However, to date, no studies have evaluated the efficacy of a smoking-cessation intervention specifically tailored to this population. This article reviews the evidence and rationale for advancing smoking-cessation treatments specifically tailored to the needs of HIV-infected persons and provides recommendations for future treatment studies.</description><subject>Acquired Immunodeficiency Syndrome - prevention & control</subject><subject>AIDS</subject><subject>Biological and medical sciences</subject><subject>Cigarette smoking</subject><subject>Disease risk</subject><subject>Epidemiology</subject><subject>HIV</subject><subject>HIV infections</subject><subject>HIV Infections - prevention & control</subject><subject>HIV/AIDS</subject><subject>Human immunodeficiency virus</subject><subject>Human viral diseases</subject><subject>Humans</subject><subject>Infections</subject><subject>Infectious diseases</subject><subject>Medical sciences</subject><subject>Physicians</subject><subject>Preventive medicine</subject><subject>Smoking Cessation</subject><subject>Time Factors</subject><subject>Viral diseases</subject><subject>Viral diseases of the lymphoid tissue and the blood. Aids</subject><issn>1058-4838</issn><issn>1537-6591</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2000</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqF0Mtu1DAUBmALUdEL8AQIGSGxasAnvqa7Mi2dkSpYTKCIjeVxHHA7sQc7EfTtm1FG0xXCG1v6P51j_Qi9BPIeiBIfKDDC1BN0BJzKQvAKno5vwlXBFFWH6DjnW0IAFOHP0CEAAamoOEL1fOhMwIuuG0JsXOutd8He428-DRkvQuts72M4xeeLi-UpNqHByy7e-fATz1zOZhue4fqXw7XvHPYZf45_nqOD1qyze7G7T9DXT5f1bF5cf7lazM6vC8s49AWrKsatLEG2giq6orYZ_0pKonjJiAPOzErw1qmSgLNGrCxTwkApW04bUTl6gt5Nczcp_h5c7nXns3XrtQkuDlnLksF41H_hWIYCxcgjtCnmnFyrN8l3Jt1rIHpbtJ6KHuHr3cRh1bnmke2aHcHbHTDZmnWbTLA-751UlSJsVG8mFYfNv1e9msxt7mPaK8bEWMV2UTHFPvfu7z426U4LSSXX8-8_9E25rD9KIvUNfQCwoaN6</recordid><startdate>20000901</startdate><enddate>20000901</enddate><creator>Niaura, Raymond</creator><creator>Shadel, William G.</creator><creator>Morrow, Kathleen</creator><creator>Tashima, Karen</creator><creator>Flanigan, Timothy</creator><creator>Abrams, David B.</creator><general>The University of Chicago Press</general><general>University of Chicago Press</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20000901</creationdate><title>Human Immunodeficiency Virus Infection, AIDS, and Smoking Cessation: The Time is Now</title><author>Niaura, Raymond ; Shadel, William G. ; Morrow, Kathleen ; Tashima, Karen ; Flanigan, Timothy ; Abrams, David B.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c451t-49945c7217f6383b3cd83802085240e154ab65fe8201eca6bc486a127f53d69e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2000</creationdate><topic>Acquired Immunodeficiency Syndrome - prevention & control</topic><topic>AIDS</topic><topic>Biological and medical sciences</topic><topic>Cigarette smoking</topic><topic>Disease risk</topic><topic>Epidemiology</topic><topic>HIV</topic><topic>HIV infections</topic><topic>HIV Infections - prevention & control</topic><topic>HIV/AIDS</topic><topic>Human immunodeficiency virus</topic><topic>Human viral diseases</topic><topic>Humans</topic><topic>Infections</topic><topic>Infectious diseases</topic><topic>Medical sciences</topic><topic>Physicians</topic><topic>Preventive medicine</topic><topic>Smoking Cessation</topic><topic>Time Factors</topic><topic>Viral diseases</topic><topic>Viral diseases of the lymphoid tissue and the blood. Aids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Niaura, Raymond</creatorcontrib><creatorcontrib>Shadel, William G.</creatorcontrib><creatorcontrib>Morrow, Kathleen</creatorcontrib><creatorcontrib>Tashima, Karen</creatorcontrib><creatorcontrib>Flanigan, Timothy</creatorcontrib><creatorcontrib>Abrams, David B.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Clinical infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Niaura, Raymond</au><au>Shadel, William G.</au><au>Morrow, Kathleen</au><au>Tashima, Karen</au><au>Flanigan, Timothy</au><au>Abrams, David B.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Human Immunodeficiency Virus Infection, AIDS, and Smoking Cessation: The Time is Now</atitle><jtitle>Clinical infectious diseases</jtitle><stitle>Clinical Infectious Diseases</stitle><addtitle>Clinical Infectious Diseases</addtitle><date>2000-09-01</date><risdate>2000</risdate><volume>31</volume><issue>3</issue><spage>808</spage><epage>812</epage><pages>808-812</pages><issn>1058-4838</issn><eissn>1537-6591</eissn><coden>CIDIEL</coden><abstract>Treatments for persons who are infected with human immunodeficiency virus (HIV) or who have developed AIDS have advanced to the point where death is no longer the inevitable outcome of diagnosis. Combination antiretroviral therapy has made HIV infection less of a terminal condition and more of a medically manageable chronic disease. Thus, efforts to improve the health status and quality of life of HIV-infected persons have become one of the highest treatment priorities for the next decade. Cigarette smoking is highly prevalent among HIV-infected persons, and quitting smoking would greatly improve the health status of these individuals. However, to date, no studies have evaluated the efficacy of a smoking-cessation intervention specifically tailored to this population. This article reviews the evidence and rationale for advancing smoking-cessation treatments specifically tailored to the needs of HIV-infected persons and provides recommendations for future treatment studies.</abstract><cop>Chicago, IL</cop><pub>The University of Chicago Press</pub><pmid>11017836</pmid><doi>10.1086/314048</doi><tpages>5</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1058-4838 |
| ispartof | Clinical infectious diseases, 2000-09, Vol.31 (3), p.808-812 |
| issn | 1058-4838 1537-6591 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_72411118 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; JSTOR Archive Collection A-Z Listing; Oxford University Press Journals All Titles (1996-Current) |
| subjects | Acquired Immunodeficiency Syndrome - prevention & control AIDS Biological and medical sciences Cigarette smoking Disease risk Epidemiology HIV HIV infections HIV Infections - prevention & control HIV/AIDS Human immunodeficiency virus Human viral diseases Humans Infections Infectious diseases Medical sciences Physicians Preventive medicine Smoking Cessation Time Factors Viral diseases Viral diseases of the lymphoid tissue and the blood. Aids |
| title | Human Immunodeficiency Virus Infection, AIDS, and Smoking Cessation: The Time is Now |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-21T03%3A56%3A40IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Human%20Immunodeficiency%20Virus%20Infection,%20AIDS,%20and%20Smoking%20Cessation:%20The%20Time%20is%20Now&rft.jtitle=Clinical%20infectious%20diseases&rft.au=Niaura,%20Raymond&rft.date=2000-09-01&rft.volume=31&rft.issue=3&rft.spage=808&rft.epage=812&rft.pages=808-812&rft.issn=1058-4838&rft.eissn=1537-6591&rft.coden=CIDIEL&rft_id=info:doi/10.1086/314048&rft_dat=%3Cjstor_proqu%3E4461276%3C/jstor_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17881840&rft_id=info:pmid/11017836&rft_jstor_id=4461276&rft_oup_id=10.1086/314048&rfr_iscdi=true |